Holland & Knight Health Dose: Staying Ahead of the Game in Healthcare Policy and Regulation

Insights from the May 7, 2024 Holland & Knight Health Dose

The Holland & Knight Health Dose is a comprehensive weekly update on legislative and regulatory developments in Washington, D.C. that impact the health sector. This newsletter aims to keep stakeholders informed and up to date on the latest happenings in the industry.

The current edition of Health Dose covers a wide range of topics, including the FAA Reauthorization, House passage of the Congressional Budget Office Data Sharing Act, and the Senate Committee on Finance’s release of a discussion draft on drug shortages. Additionally, the House Ways and Means Committee is set to mark up legislation to extend telehealth waivers, FDA officials will be appearing before the E&C Subcommittee, and there will be hearings on administrative and regulatory burdens in healthcare in both the House and Senate.

Last week’s highlights included hearings on cyberattacks, Medicaid and LTSS, maternal mortality, workforce diversity, Medicare and Social Security Trustees releasing their annual reports, HHS releasing Cost Sharing FAQs, HHS releasing draft guidance for Second Cycle Medicare Drug Price Negotiation Program, FDA releasing Laboratory Developed Test Final Rule and finalizing a DACA Health Coverage Rule. Finally there were new appointments made to Medicaid CHIP Payment & Access Commission (MACPAC).

Readers can stay informed by visiting the link provided to access the full Health Dose newsletter.

Leave a Reply